Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 6-7, Juin–Juillet 2010
Page(s) 652 - 654
Section Forum
DOI https://doi.org/10.1051/medsci/2010266-7652
Publié en ligne 15 juin 2010
  1. Gratwohl A, Baldomero H. Trends of hematopoietic stem cell transplantation in the third millennium. Curr Opin Hematol 2009 ; 16 : 420-6.
  2. Gratwohl A, Baldomero H, Frauendorfer K, et al. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products. Bone Marrow Transplant 2008 ; 41 : 687-705.
  3. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A. EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplant 2006 ; 37 : 1069-85.
  4. Gratwohl A, Baldomero H, Frauendorfer K, et al. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplant 2007 ; 39 : 71-87.
  5. Gratwohl A, Baldomero H, Schwendener A, et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009 ; 43 : 275-91.
  6. LeMaistre CF, Loberiza FR Jr. What is quality in a transplant program? Biol Blood Marrow Transplant 2005 ; 11 : 241-6.
  7. Lartigau E, Coche-Dequeant B, Dumortier V, et al. Experience feed back committee in radiotherapy (CREx): a compulsory tool for security management evaluation at two years. Cancer Radiother 2008 ; 12 : 610-3.
  8. Apperley J. Just another cost increasing exercise (JACIE)? Bone Marrow Transplant 2004 ; 34 : 835-8.
  9. Pamphilon D, Apperley JF, Samson D, et al. JACIE Accreditation in 2008: Demonstrating Excellence in Stem Cell Transplantation. Hematol Oncol Stem Cell Ther 2009 ; 2 : 311-9.
  10. Gratwohl A, Brand R, Niederwieser D, et al. Impact of JACIE accreditation on outcome after haematopoietic stem cell transplantation: an EBMT megafile registry based analysis. Bone Marrow Transplant 2010 ; 45 : S63 (abstract).
  11. Klingebiel T, Cornish J, Labopin M, et al. Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplant in children with very-high risk acute lymphoblastic leukemia. Impact of center size: an analysis on behalf of the acute leukemia and pediatric disease working parties of the European blood and marrow transplant group. Blood 2009 ; 115 : 3437-46.
  12. Afolalu B, Troidle L, Osayimwen O, et al. Technique failure and center size in a large cohort of peritoneal dialysis patients in a defined geographic area. Perit Dial Int 2009 ; 29 : 292-6.
  13. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986 ; 314 : 729-35.
  14. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005 ; 23 : 5074-87.
  15. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001 ; 97 : 2962-71.
  16. Niederwieser D, Maris M, Shizuru JA, et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003 ; 101 : 1620-9.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.